|
1
|
Xia C, Yang Y, Kong F, Kong Q and Shan C:
MiR-143-3p inhibits the proliferation, cell migration and invasion
of human breast cancer cells by modulating the expression of MAPK7.
Biochimie. 147:98–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:E13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soudyab M, Iranpour M and Ghafouri-Fard S:
The role of long non-coding RNAs in breast cancer. Arch Iran Med.
19:508–517. 2016.PubMed/NCBI
|
|
7
|
Greco S, Gorospe M and Martelli F:
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell
Cardiol. 83:142–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hou L, Tu J, Cheng F, Yang H, Yu F, Wang
M, Liu J, Fan J and Zhou G: Long noncoding RNA ROR promotes breast
cancer by regulating the TGF-β pathway. Cancer Cell Int.
18:1422018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bai Y, Zhou X, Huang L, Wan Y, Li X and
Wang Y: Long noncoding RNA EZR-AS1 promotes tumor growth and
metastasis by modulating Wnt/β-catenin pathway in breast cancer.
Exp Ther Med. 16:2235–2242. 2018.PubMed/NCBI
|
|
12
|
Han YJ, Boatman SM, Zhang J, Du XC, Yeh
AC, Zheng Y, Mueller J and Olopade OI: LncRNA BLAT1 is upregulated
in basal-like breast cancer through epigenetic modifications. Sci
Rep. 8:155722018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Y, Xu X, Wang T, Li Y, You W, Fu J,
Liu Y, Jin S, Ji Q, Zhao W, et al: The EGFR/miR-338-3p/EYA2 axis
controls breast tumor growth and lung metastasis. Cell Death Dis.
8:e29282017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Hu J, Song H, Xu H, Wu C, Zhao B,
Xie D, Wu T, Zhao J and Fang L: MiR-143-3p targeting LIM domain
kinase 1 suppresses the progression of triple-negative breast
cancer cells. Am J Transl Res. 9:2276–2285. 2017.PubMed/NCBI
|
|
15
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu H, Zeng Y, Zhou CC and Ye W:
SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the
tumorigenesis of cervical cancer cells. Arch Biochem Biophys.
637:1–8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen
JJ, Chen WJ, Sun WY, Liu XM and Chen JB: LncRNA SNHG16 functions as
an oncogene by sponging MiR-4518 and up-regulating PRMT5 expression
in glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan P, Cao W, Zang Q, Li G, Guo X and Fan
J: The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance
of hepatocellular carcinoma cells via modulating autophagy. Biochem
Biophys Res Commun. 478:1067–1073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene exp ression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yue B, Cai D, Liu C, Fang C and Yan D:
Linc00152 functions as a competing endogenous RNA to confer
oxaliplatin resistance and holds prognostic values in colon cancer.
Mol Ther. 24:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guil S and Esteller M: RNA-RNA
interactions in gene regulation: The coding and noncoding players.
Trends Biochem Sci. 40:248–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun X, Dai G, Yu L, Hu Q, Chen J and Guo
W: MiR-143-3p inhibits the proliferation, migration and invasion in
osteosarcoma by targeting FOSL2. Sci Rep. 8:6062018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Fang C, Wang Y, Zhang J, Yu J,
Zhang Y, Wang X and Zhong J: COL1A1: A potential therapeutic target
for colorectal cancer expressing wild-type or mutant KRAS. Int J
Oncol. 53:1869–1880. 2018.PubMed/NCBI
|
|
24
|
Jurikova M, Danihel L, Polak S and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo JL, Gu SQ, Li Y and Zhang XY:
Evaluation of clinical significance of endoglin expression during
breast cancer and its correlation with ER and PCNA. Eur Rev Med
Pharmacol Sci. 21:5402–5407. 2017.PubMed/NCBI
|
|
26
|
Hu L, Li HL, Li WF, Chen JM, Yang JT, Gu
JJ and Xin L: Clinical significance of expression of proliferating
cell nuclear antigen and E-cadherin in gastric carcinoma. World J
Gastroenterol. 23:3721–3729. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ahmed M, Rubio IT, Klaase JM and Douek M:
Surgical treatment of nonpalpable primary invasive and in situ
breast cancer. Nat Rev Clin Oncol. 12:645–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee J, Park HY, Kim WW, Lee SJ, Jeong JH,
Kang SH, Jung JH and Chae YS: Biological function of long noncoding
RNA snaR in HER2-positive breast cancer cells. Tumour Biol.
39:10104283177073742017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peter S, Borkowska E, Drayton RM, Rakhit
CP, Noon A, Chen W and Catto JW: Identification of differentially
expressed long noncoding RNAs in bladder cancer. Clin Cancer Res.
20:5311–5321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li H, Yuan X, Yan D, Li D, Guan F, Dong Y,
Wang H, Liu X and Yang B: Long Non-Coding RNA MALAT1 decreases the
sensitivity of resistant glioblastoma cell lines to temozolomide.
Cell Physiol Biochem. 42:1192–1201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X,
Zhang W, Deng H, Zhou M, Peng S, et al: AFAP1-AS1, a long noncoding
RNA upregulated in lung cancer and promotes invasion and
metastasis. Tumour Biol. 37:729–737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Yang H, Deng Z, Su Y, Fang Q and
Yin Z: HOX antisense lincRNA HOXA-AS2 promotes tumorigenesis of
hepatocellular carcinoma. Cell Physiol Biochem. 40:287–296. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao W, Fu H, Zhang S, Sun S and Liu Y:
LncRNA SNHG16 drives proliferation, migration, and invasion of
hemangioma endothelial cell through modulation of miR-520d-3p/STAT3
axis. Cancer Med. 29:102018.
|
|
37
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7:136162016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li
LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates
breast cancer cell plasticity during EMT and MET plasticity by
differentially sponging miR-200b/c and let-7b. Sci Signal.
10:4832017. View Article : Google Scholar
|
|
39
|
Liu J, Shen JX, Wu HT, Li XL, Wen XF, Du
CW and Zhang GJ: Collagen 1A1 (COL1A1) promotes metastasis of
breast cancer and is a potential therapeutic target. Discov Med.
25:211–223. 2018.PubMed/NCBI
|
|
40
|
Kobayashi M, Saito A, Tanaka Y, Michishita
M, Kobayashi M, Irimajiri M, Kaneda T, Ochiai K, Bonkobara M,
Takahashi K, et al: MicroRNA expression profiling in canine
prostate cancer. J Vet Med Sci. 79:719–725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu
LH, Chen W, Wang LY, Zhao Y, Tian B and Hua YJ: The essential role
of H19 contributing to cisplatin resistance by regulating
glutathione metabolism in high-grade serous ovarian cancer. Sci
Rep. 6:260932016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiong Z, Wang L and Wang Q: LncRNA
MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting
SOX2. J Cell Mol Med. 29:102018.
|
